Investigating the role of Follistatin in oral cancer progression
Single-cell profiling of Follistatin within the Tumor Landscape of Oral Squamous Cell Carcinoma
This study is looking at how a protein called Follistatin affects mouth cancer, aiming to find new ways to diagnose and treat this type of cancer by understanding how it helps the cancer grow and spread.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of New York at Buffalo NIH-funded |
| Lab location | 1 site (Amherst, United States) |
| Project ID | NIH-11067208 on NIH RePORTER |
What this research studies
This research focuses on understanding how Follistatin (FST), a protein found in the body, influences the behavior of oral squamous cell carcinoma (OSCC), a type of cancer affecting the mouth. By analyzing cancer cells and their interactions with surrounding cells, the study aims to uncover how FST contributes to cancer growth and spread. Researchers will use advanced techniques, including gene manipulation and single-cell RNA sequencing, to explore the mechanisms by which FST may promote tumor aggression. The ultimate goal is to identify new biomarkers for early diagnosis and potential therapeutic targets for OSCC.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with oral squamous cell carcinoma or those at high risk for developing this type of cancer.
Not a fit: Patients with other types of cancers or those without a diagnosis of oral squamous cell carcinoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and targeted therapies for patients with oral squamous cell carcinoma.
How similar studies have performed: Previous research has shown promising results in understanding the role of similar proteins in cancer progression, suggesting that this approach may yield valuable insights.
Where this research is happening
Amherst, United States
- State University of New York at Buffalo — Amherst, United States (Active)
Researchers
- Principal investigator: Sosa, Jennifer — State University of New York at Buffalo
- Study coordinator: Sosa, Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.